APA-Zitierstil (7. Ausg.)

Ramírez, A., & Frölich, L. (2014). SUCLG2 identified as both a determinator of CSF A beta(1-42) levels and an attenuator of cognitive decline in Alzheimer's disease. Human molecular genetics, 23(24), .

Chicago-Zitierstil (17. Ausg.)

Ramírez, Alfredo, und Lutz Frölich. "SUCLG2 Identified as Both a Determinator of CSF A Beta(1-42) Levels and an Attenuator of Cognitive Decline in Alzheimer's Disease." Human Molecular Genetics 23, no. 24 (2014).

MLA-Zitierstil (9. Ausg.)

Ramírez, Alfredo, und Lutz Frölich. "SUCLG2 Identified as Both a Determinator of CSF A Beta(1-42) Levels and an Attenuator of Cognitive Decline in Alzheimer's Disease." Human Molecular Genetics, vol. 23, no. 24, 2014.